Signant Health: SmartSignals Telemedicine update
Trial technology specialist Signant Health has updated its SmartSignals Telemedicine platform with the intent of optimizing remote and decentralized trial operations. The updates are intended to help clients meet ever-changing customer needs, industry demands, and global regulatory requirements.
“Release 6.0 includes important strategic updates that continue to position Signant SmartSignals Telemedicine as a leading platform for video-enabled engagement between sites and patients, specifically adapted for use in clinical trials,” said Andrew Walker, director of product management for the platform. “With these latest enhancements and investments, we are well positioned to address the increasingly decentralized clinical research landscape.”